TY - JOUR
T1 - Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States
AU - Baker, Arthur W.
AU - La Hoz, Ricardo M.
AU - Anesi, Judith A.
AU - Kwon, Jennie H.
AU - Wasylyshyn, Anastasia I.
AU - Ford, Emily S.
AU - Harrington, Susan M.
AU - Miller, Melissa B.
AU - Weber, David J.
AU - Sickbert-Bennett, Emily E.
AU - Talbot, Thomas R.
AU - Nguyen, M. Hong
AU - Kramer, Kailey Hughes
AU - Nickel, Katelin B.
AU - Ziegler, Matthew J.
AU - Arocha, Doramarie
AU - Henderson, Charles
AU - Lokhnygina, Yuliya
AU - Maged, Ahmed
AU - Haridy, Salah
AU - Alexander, Barbara D.
AU - Stout, Jason E.
AU - Anderson, Deverick J.
N1 - Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
PY - 2026/12/15
Y1 - 2026/12/15
N2 - Background Data on the epidemiology of healthcare facility-associated (HCFA) nontuberculous mycobacteria (NTM) are sparse. We performed a multicenter longitudinal cohort study of HCFA NTM epidemiology. Methods We retrospectively analyzed positive cultures for NTM performed from 2012 through 2020 within a network of 10 US academic hospitals and associated clinics. A unique NTM episode was defined as a patient's first positive culture for a particular NTM species and specimen source category (pulmonary vs extrapulmonary). Episodes linked to specimens obtained on day 3 or later of hospitalization were classified as hospital-onset (HO). Seven hospitals contributed at least 12 months of data prior to January 2014. Within this closed cohort, incidence rate ratios (IRRs) and trends in incidence from 2014 through 2020 were estimated, assuming the number of episodes followed the Poisson distribution. Results A total of 12 855 unique NTM episodes occurred from 2012 through 2020 during 19 248 137 patient-days of surveillance. Of these episodes, 3045 (24%) were HO. HO incidence rates were highly variable among hospitals, with a median hospital rate of 1.06 episodes per 10 000 patient-days (range, 0.35–5.48). Within the 7-hospital closed cohort from 2014 through 2020, the incidence rate of HO episodes decreased from 2.29 to 1.42 episodes per 10 000 patient-days (IRR, 0.62; 95% confidence interval,.53–.73; P <.0001). Conclusions Incidence rates of HO NTM episodes decreased from 2014 through 2020, but rates varied substantially among hospitals. These results provide comprehensive data on HO NTM isolation, including benchmark rates that can be used to improve hospital-based NTM surveillance.
AB - Background Data on the epidemiology of healthcare facility-associated (HCFA) nontuberculous mycobacteria (NTM) are sparse. We performed a multicenter longitudinal cohort study of HCFA NTM epidemiology. Methods We retrospectively analyzed positive cultures for NTM performed from 2012 through 2020 within a network of 10 US academic hospitals and associated clinics. A unique NTM episode was defined as a patient's first positive culture for a particular NTM species and specimen source category (pulmonary vs extrapulmonary). Episodes linked to specimens obtained on day 3 or later of hospitalization were classified as hospital-onset (HO). Seven hospitals contributed at least 12 months of data prior to January 2014. Within this closed cohort, incidence rate ratios (IRRs) and trends in incidence from 2014 through 2020 were estimated, assuming the number of episodes followed the Poisson distribution. Results A total of 12 855 unique NTM episodes occurred from 2012 through 2020 during 19 248 137 patient-days of surveillance. Of these episodes, 3045 (24%) were HO. HO incidence rates were highly variable among hospitals, with a median hospital rate of 1.06 episodes per 10 000 patient-days (range, 0.35–5.48). Within the 7-hospital closed cohort from 2014 through 2020, the incidence rate of HO episodes decreased from 2.29 to 1.42 episodes per 10 000 patient-days (IRR, 0.62; 95% confidence interval,.53–.73; P <.0001). Conclusions Incidence rates of HO NTM episodes decreased from 2014 through 2020, but rates varied substantially among hospitals. These results provide comprehensive data on HO NTM isolation, including benchmark rates that can be used to improve hospital-based NTM surveillance.
KW - healthcare-associated infections
KW - hospital epidemiology
KW - infection prevention
KW - infection surveillance
KW - nontuberculous mycobacteria
UR - https://www.scopus.com/pages/publications/105029528295
U2 - 10.1093/cid/ciaf169
DO - 10.1093/cid/ciaf169
M3 - Article
C2 - 40357718
AN - SCOPUS:105029528295
SN - 1058-4838
VL - 81
SP - 1106
EP - 1114
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 6
ER -